193 related articles for article (PubMed ID: 29286542)
1. Effects of Initiating Abstinence from Alcohol on Daily Craving and Negative Affect: Results from a Pharmacotherapy Clinical Trial.
Hallgren KA; Delker BC; Simpson TL
Alcohol Clin Exp Res; 2018 Mar; 42(3):634-645. PubMed ID: 29286542
[TBL] [Abstract][Full Text] [Related]
2. Moderation of Prazosin's Efficacy by Alcohol Withdrawal Symptoms.
Sinha R; Wemm S; Fogelman N; Milivojevic V; Morgan PM; Angarita GA; Hermes G; Fox HC
Am J Psychiatry; 2021 May; 178(5):447-458. PubMed ID: 33207935
[TBL] [Abstract][Full Text] [Related]
3. Trajectories of drinking urges and the initiation of abstinence during cognitive-behavioral alcohol treatment.
Hallgren KA; McCrady BS; Epstein EE
Addiction; 2016 May; 111(5):854-65. PubMed ID: 26709608
[TBL] [Abstract][Full Text] [Related]
4. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
Verplaetse TL; Ralevski E; Roberts W; Gueorguieva R; McKee SA; Petrakis IL
Alcohol Clin Exp Res; 2019 Apr; 43(4):741-746. PubMed ID: 30698839
[TBL] [Abstract][Full Text] [Related]
5. Changes in Hypothesized Mechanisms of Change Before and After Initiating Abstinence in Cognitive-Behavioral Therapy for Women With Alcohol Use Disorder.
Hallgren KA; Epstein EE; McCrady BS
Behav Ther; 2019 Nov; 50(6):1030-1041. PubMed ID: 31735239
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms of behavior change during alcohol treatment among negative affect drinkers: A time-varying effect model analysis using 84 consecutive days of ecological momentary assessment.
Zhao J; Linn BK; Stasiewicz PR; Wilding GE; LaBarre C; Bradizza CM
Psychol Addict Behav; 2024 Feb; 38(1):36-46. PubMed ID: 37199961
[TBL] [Abstract][Full Text] [Related]
7. Effects of Prazosin on Provoked Alcohol Craving and Autonomic and Neuroendocrine Response to Stress in Alcohol Use Disorder.
Milivojevic V; Angarita GA; Hermes G; Sinha R; Fox HC
Alcohol Clin Exp Res; 2020 Jul; 44(7):1488-1496. PubMed ID: 32449942
[TBL] [Abstract][Full Text] [Related]
8. Prazosin effects on stress- and cue-induced craving and stress response in alcohol-dependent individuals: preliminary findings.
Fox HC; Anderson GM; Tuit K; Hansen J; Kimmerling A; Siedlarz KM; Morgan PT; Sinha R
Alcohol Clin Exp Res; 2012 Feb; 36(2):351-60. PubMed ID: 21919922
[TBL] [Abstract][Full Text] [Related]
9. Affect, motivation, temptation, and drinking among alcohol-dependent outpatients trying to maintain abstinence: An Ecological Momentary Assessment study.
Waters AJ; Schoenmakers TM; Snelleman M; Szeto EH; Franken IHA; Hendriks VM; van de Mheen D
Drug Alcohol Depend; 2020 Jan; 206():107626. PubMed ID: 31786398
[TBL] [Abstract][Full Text] [Related]
10. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
[TBL] [Abstract][Full Text] [Related]
11. Baclofen for alcohol use disorder.
Agabio R; Saulle R; Rösner S; Minozzi S
Cochrane Database Syst Rev; 2023 Jan; 1(1):CD012557. PubMed ID: 36637087
[TBL] [Abstract][Full Text] [Related]
12. A Randomized, Placebo-controlled, Clinical Trial of Prazosin for the Treatment of Alcohol Use Disorder.
Wilcox CE; Tonigan JS; Bogenschutz MP; Clifford J; Bigelow R; Simpson T
J Addict Med; 2018; 12(5):339-345. PubMed ID: 29664896
[TBL] [Abstract][Full Text] [Related]
13. Alcohol craving and withdrawal at treatment entry prospectively predict alcohol use outcomes during outpatient treatment.
Martins JS; Fogelman N; Wemm S; Hwang S; Sinha R
Drug Alcohol Depend; 2022 Feb; 231():109253. PubMed ID: 34998258
[TBL] [Abstract][Full Text] [Related]
14. Differing patterns of stress and craving across the day in moderate-heavy alcohol consumers during their typical drinking routine and an imposed period of alcohol abstinence.
Mayhugh RE; Rejeski WJ; Petrie MR; Laurienti PJ; Gauvin L
PLoS One; 2018; 13(4):e0195063. PubMed ID: 29668736
[TBL] [Abstract][Full Text] [Related]
15. Baclofen: its effectiveness in reducing harmful drinking, craving, and negative mood. A meta-analysis.
Rose AK; Jones A
Addiction; 2018 Aug; 113(8):1396-1406. PubMed ID: 29479827
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Drinking Risk Levels as Outcomes in Alcohol Pharmacotherapy Trials: A Secondary Analysis of 3 Randomized Clinical Trials.
Falk DE; O'Malley SS; Witkiewitz K; Anton RF; Litten RZ; Slater M; Kranzler HR; Mann KF; Hasin DS; Johnson B; Meulien D; Ryan M; Fertig J;
JAMA Psychiatry; 2019 Apr; 76(4):374-381. PubMed ID: 30865232
[TBL] [Abstract][Full Text] [Related]
17. Predictors of abstinence, no heavy drinking days, and a 2-level reduction in World Health Organization drinking levels during treatment for alcohol use disorder in the COMBINE study.
Wallach JD; Gueorguieva R; Phan H; Witkiewitz K; Wu R; O'Malley SS
Alcohol Clin Exp Res; 2022 Jul; 46(7):1331-1339. PubMed ID: 35616436
[TBL] [Abstract][Full Text] [Related]
18. Reductions in WHO risk drinking levels correlate with alcohol craving among individuals with alcohol use disorder.
Tuchman FR; Hallgren KA; Richards DK; Aldridge A; Anton RF; Aubin HJ; Kranzler HR; Mann K; O'Malley SS; Witkiewitz K
Alcohol Clin Exp Res (Hoboken); 2024 Feb; 48(2):420-429. PubMed ID: 38149364
[TBL] [Abstract][Full Text] [Related]
19. A randomized controlled clinical trial of prazosin for alcohol use disorder in active duty soldiers: Predictive effects of elevated cardiovascular parameters.
Raskind MA; Williams T; Holmes H; Hart K; Crews L; Poupore EL; Thomas RG; Darnell J; Daniels C; Goke K; Hendrickson R; Terry G; Mayer C; Simpson T; Saxon A; Rasmussen D; Peskind ER
Alcohol Clin Exp Res (Hoboken); 2023 Feb; 47(2):348-360. PubMed ID: 36809662
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of Gabapentin for the Treatment of Alcohol Use Disorder in Patients With Alcohol Withdrawal Symptoms: A Randomized Clinical Trial.
Anton RF; Latham P; Voronin K; Book S; Hoffman M; Prisciandaro J; Bristol E
JAMA Intern Med; 2020 May; 180(5):728-736. PubMed ID: 32150232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
